Sarcoma is a rare cancer that often begins as a painless lump. Experts stress that early diagnosis improves treatment and ...

The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...

Bavencio and gemcitabine show efficacy in advanced leiomyosarcoma, with a 20% objective response rate and 71% disease control rate. Higher TIL density correlates with improved objective response rates ...

Uterine leiomyosarcoma is a rare and aggressive cancer that occurs in the uterus. Individuals usually require a hysterectomy. Treatments can also include chemotherapy or radiotherapy. Leiomyosarcoma ...

Sarcomas constitute a group of over seventy cancers, each biologically unique, which develop in the bones and the soft ...

Public sarcoma awareness brought about by Sarcoma Awareness Month has led to research & treatment advances, & potentially fewer misdiagnoses.

Modern treatments like limb-sparing surgery have revolutionised patient outcomes, but awareness and timely consultation ...

ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...

RGCIRC’s Soft Tissue Sarcoma Summit 2026 in New Delhi brought together global experts to advance multidisciplinary care, ...

Sarcoma Awareness Month, Law Office of Justin C. Frankel is raising awareness about sarcoma, a rare form of cancer ...